Viewing Study NCT05429593


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-01-02 @ 11:13 PM
Study NCT ID: NCT05429593
Status: COMPLETED
Last Update Posted: 2024-08-07
First Post: 2022-06-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Research Study Investigating How Semaglutide and Dapagliflozin Act in Your Body When Dosed in One Tablet
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module